Synergy in action
Early Identification of Patient Variability and Pharmacogenomic. A new approach to the Development of Precision Medicines.
Oesophageal Cancer
An unmet clinical need: to identify targets for future Precision Medicine Approaches.
Enabling Precision Medicine in Early Rheumatoid Arthritis
Predicting methotrexate (MTX) response and toxicity using an integrated polyomic response.
FutureMS: Developing predictive tools
Creating a Scotland-wide informatics, imaging and genetic platform to improve Multiple Sclerosis clinical management and decision-making.